Business Standard

Outcome of board meeting of Hester Biosciences

Image

Capital Market

Held on 22 March 2017

Hester Biosciences announced that the Board of Directors at its meeting held on 22 March 2017 have decided the following -

To make investment in the Partnership Firm namely, Texas Laboratories, Mehsana, Gujarat.

To accept the buy-back offer of its Associate Company i.e. Leruarua Vetcare (Proprietary), Botswana.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Mar 22 2017 | 11:38 AM IST

Explore News